Viewing Study NCT01138605


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-24 @ 1:12 AM
Study NCT ID: NCT01138605
Status: COMPLETED
Last Update Posted: 2019-05-01
First Post: 2010-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV
Sponsor: Janssen Sciences Ireland UC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module